Biosig completes 1000 patient cases with its signal processing system for electrophysiology

Westport, ct, june 30, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that physicians have completed 1000 patient cases with its technology across nine installation sites.
BSGM Ratings Summary
BSGM Quant Ranking